TRDA

$5.38-5.28%website ↗⬇ financials (.py)

Entrada Therapeutics, Inc.

Market Cap

$209M

Live price × shares (2026-09-17)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

-0.26

59mo monthly vs SPY

P/E (TTM)

N/M

Price / TTM net income

P/S (TTM)

44.6

Price / TTM revenue

P/B

0.9

Price / stockholders equity

EV/EBITDA

—

TTM

Price Chart

Loading…

Signals

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro →

Velocity Score

54.86x

Sell Rate (90d)

7235.58/mo

Sell Baseline

338.29/mo

Unique Sellers (90d)

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-09-09	2026-09-09	MPM BioVentures 2014, L.P.	10% Owner	Sale	28.8K	$7.13	$206K	3.89M	View
2026-09-08	2026-09-09	MPM BioVentures 2014, L.P.	10% Owner	Sale	192.5K	$7.41	$1.43M	3.91M	View
2026-09-04	2026-09-09	MPM BioVentures 2014, L.P.	10% Owner	Sale	38.5K	$7.11	$274K	4.11M	View
2026-09-03	2026-09-03	MPM BioVentures 2014, L.P.	10% Owner	Sale	32.3K	$7.17	$231K	4.14M	View
2026-09-02	2026-09-03	MPM BioVentures 2014, L.P.	10% Owner	Sale	25.1K	$7.19	$181K	4.18M	View

1–5 of 24

1 / 5

TRDA

Signals

Factor Profile

Reporting Insiders

Recent News

Entrada Therapeutics, Inc. (TRDA)

Factor Profile

Date	Insider	Type	Shares	Value
2026-09-09	MPM BioVentures 2014, L.P.	S	28,837	$205,607.81
2026-09-08	MPM BioVentures 2014, L.P.	S	192,500	$1M
2026-09-04	MPM BioVentures 2014, L.P.	S	38,500	$273,735
2026-09-03	MPM BioVentures 2014, L.P.	S	32,263	$231,325.71
2026-09-02	MPM BioVentures 2014, L.P.	S	25,131	$180,691.89